A previous study found that CD8+ T cells in the tumor microenvironment have high expression levels of exhausted molecules, such as PD-1 and ITIM domains, were prone to exhaustion (25), and influence disease progression and clinical outcome (26). The gene discussed is CD8A; the disease is neoplasm.